Klaus Breiner
InvestorManaging Partner at Pureos Bioventures
Switzerland
Writes $100K – $5M checks · typically $1.5M
Find your path to Klaus
373 people in our graph can introduce you to Klaus.
Sign up to see every warm intro you have to Klaus
- Paths you didn't know you had: your email and LinkedIn already hold routes to Klaus. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Contact· self-published, not guessed
Experience
- Pureos Partners AGCo-founder and Managing Directorcurrent2021 — presentFreienbach, Schwyz, Switzerland
- VICO Therapeutics B.V.Non-executive Directorcurrent2021 — presentLeiden, South Holland, Netherlands
- Pureos BioventuresManaging Partnercurrent2017 — presentPfäffikon, Schwyz, Switzerland
- BB Biotech VenturesPartnercurrent2004 — presentZurich, Switzerland
- Vaximm AGCo-Founder & Vice-Chairman (Executive Chairman till mid-2016)2008 — 2022Basel, Basel, Switzerland
- ORTHOCONBoard Director2006 — 2021Irvington, New York, United States
- BellevueSenior Adviser Private Equity2004 — 2021Küsnacht, Zurich, Switzerland
- Alpex Pharma SABoard Director2007 — 2020Mezzovico, TI, Switzerland
- AM-PharmaBoard Director2011 — 2019
- Pevion Biotech AGBoard Director2007 — 2011
- Glycart Biotechnology AGBoard Director2003 — 2004Zurich, Switzerland
- Global Life Science VenturesInvestment Manager2001 — 2004Greater Munich Metropolitan Area
- Booz Allen HamiltonAssociate2000 — 2001
- ETH ZurichPost-doctoral Fellow1999 — 2000
- ZMBH - Universität HeidelbergPost-doctoral Fellow1998 — 1999
- ZMBH - Universität HeidelbergResearch Associate1995 — 1998
Skills & more
Business Strategy8Mergers1Private Equity9Venture Capital24Start-ups14Mergers & Acquisitions12Biotechnology37Lifesciences11Strategy7Medical Devices4Technology Transfer8Corporate Development12
+12 more
BiopharmaceuticalsPharmaceutical IndustryCommercializationLicensingClinical DevelopmentAngel InvestingDrug DevelopmentR&DDrug DiscoveryOncologyClinical TrialsImmunologyFrom Klaus's professional profile.
Investments
Investor
ImcheckNatural Dental ImplantsTridek OneVaximm
Per curated public sources.
Colleagues at Pureos Bioventures
Anne Grahl
Associate at Pureos Bioventures
Butrint Aliu
Analyst at Pureos Bioventures
Christian Altorfer
CFO/COO at Pureos Bioventures
Dominik Escher
Managing Partner at Pureos Bioventures
Dragan Grabulovski
Venture Partner at Pureos Bioventures
Lars Nieba
Venture Partner at Pureos Bioventures
Martin Münchbach
Managing Partner at Pureos Bioventures
Veronica Gambillara Fonck
Partner at Pureos Bioventures
Network3
Anne Grahl
Associate at Pureos Bioventures
Dominik Escher
Managing Partner at Pureos Bioventures
Dragan Grabulovski
Venture Partner at Pureos Bioventures
Investors connected to Klaus in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Klaus Breiner?
- Managing Partner at Pureos Bioventures
- Where does Klaus Breiner work?
- Klaus Breiner is Managing Partner at Pureos Bioventures.
- What check size does Klaus Breiner write?
- Klaus Breiner typically writes checks of $100K – $5M.
- What companies has Klaus Breiner invested in?
- Investments tracked here include Imcheck, Natural Dental Implants, Tridek One, Vaximm.
- Where did Klaus Breiner go to school?
- Klaus Breiner studied at Heidelberg University (Ph.D. (Dr.rer.nat.), Biochemistry and Molecular Biology); The University of North Carolina at Chapel Hill (Master of Arts (M.A.), Chemistry); University of Düsseldorf (Chemistry).
Same school
Also attended Heidelberg University101
Mojca SkoberneEntrepreneur in Residence at GV (Google Ventures)Keita Yazakiシニア・アソシエイト (Senior Associate) at CyberAgent CapitalMarc MoesserPrincipal at redalpineGrace SchattnerChief of Staff at TitletownTechJan Claudio MuñozInvestor at Backbone VenturesLena ThiedeCo-Founder & General Partner at Planet A Ventures
+ 95 more
Also attended The University of North Carolina at Chapel Hill543
Clint MyersInvestor at RevolutionMahati SridharPartner, Rise of the Rest at RevolutionSoul DayanInvestor at True VenturesAlexander LimInvestor at IVP (Institutional Venture Partners)Alex TaubPrincipal at QED InvestorsTroy ArnoldPartner, Echo Health Advisors at Echo Health Ventures
+ 537 more
Also attended University of Düsseldorf32
Ruslan BekbulatovInvestment Principal at Robert Bosch Venture CapitalMatthias LaisManaging Director at neosfer GmbHTheodor SchultePrincipal at EnBW New Ventures GmbHIsabella FandrychGeneral Partner at Nucleus CapitalAntje Hensel-RothChief People and External Affairs Officer at Intermediate Capital GroupAvishai FortResearch Analyst at Sphera Funds Management
+ 26 more
Also attended FernUniversität in Hagen30
Wolfgang DenglerContact for financing questions at Bayern KapitalSiyana AsenovaFinance Manager at Planet A VenturesLars SingbartlSenior Advisor & Chairman at BlockwallJohannes ClaussSerial Entrepreneur, Investor and Mentor at tokentus investment AGJanosch KühnInvestor at BLN CapitalAlexander JekatInvestment Analyst at Brandenburg Kapital
+ 24 more

















































